Calreticulin, a potential vascular regulatory protein, reduces intimal hyperplasia after arterial injury. 1997

E Dai, and M Stewart, and B Ritchie, and N Mesaeli, and S Raha, and D Kolodziejczyk, and M L Hobman, and L Y Liu, and W Etches, and N Nation, and M Michalak, and A Lucas
Cardiovascular Disease Research Group, University of Alberta.

Both thrombotic and inflammatory responses to arterial injury have been implicated in atherosclerotic plaque growth. Calreticulin is a ubiquitous calcium-binding protein with antithrombotic activity and, in addition, is associated with leukocyte activation. We are investigating calreticulin as a potential vascular regulatory protein. The development of intimal hyperplasia was studied at sites of balloon injury in iliofemoral arteries from 91 rats. Calreticulin was infused directly into the artery immediately before balloon injury, and plaque growth was then assessed at 4 weeks' follow-up. Parallel studies of the effects of each calreticulin domain as well as a related calcium-binding protein, calsequestrin, were examined. The effects of calreticulin on platelet activation, clot formation, and mononuclear cell migration were also studied. When infused before balloon injury in rat iliofemoral arteries, calreticulin, or its high-capacity Ca(2+)-binding C domain, significantly reduces plaque development, whereas calsequestrin, a related calcium-binding protein that lacks the multifunctional nature of calreticulin, does not decrease plaque area (saline: 0.037 +/- 0.007 mm2, calsequestrin: 0.042 +/- 0.021 mm2, calreticulin: 0.003 +/- 0.002 mm2, n = 46, P < .04). The N domain and more specifically the P domain, a low-capacity, high-affinity calcium-binding domain in calreticulin, do not reduce intimal hyperplasia (N + P domain: 0.038 +/- 0.012 mm2, C domain: 0.003 +/- 0.002 mm2, n = 45 rats, P < .0001). Calreticulin reduces macrophage and T cell staining in the arterial wall after injury but has no direct effect on monocyte migration in vitro (percent medial area staining positive for macrophage 24 hours after injury (N + P: 4.06 +/- 1.42, calreticulin: 0.273 +/- 0.02; n = 26, P < .009). Calreticulin does, however, reduce platelet-dependent whole blood clotting time, in vitro (baseline: 78.23 +/- 2.04 seconds, calreticulin: 113.5 +/- 1.95 seconds; n = 5, P < .002). We conclude that calreticulin significantly reduces intimal hyperplasia after arterial injury, potentially acting as a vascular regulatory protein.

UI MeSH Term Description Entries
D006965 Hyperplasia An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells. Hyperplasias
D007083 Iliac Artery Either of two large arteries originating from the abdominal aorta; they supply blood to the pelvis, abdominal wall and legs. Deep Circumflex Iliac Artery,Arteries, Iliac,Artery, Iliac,Iliac Arteries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002135 Calcium-Binding Proteins Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS. Calcium Binding Protein,Calcium-Binding Protein,Calcium Binding Proteins,Binding Protein, Calcium,Binding Proteins, Calcium,Protein, Calcium Binding,Protein, Calcium-Binding
D002155 Calsequestrin Acidic protein found in SARCOPLASMIC RETICULUM that binds calcium to the extent of 700-900 nmoles/mg. It plays the role of sequestering calcium transported to the interior of the intracellular vesicle.
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis

Related Publications

E Dai, and M Stewart, and B Ritchie, and N Mesaeli, and S Raha, and D Kolodziejczyk, and M L Hobman, and L Y Liu, and W Etches, and N Nation, and M Michalak, and A Lucas
June 2017, Molecular medicine (Cambridge, Mass.),
E Dai, and M Stewart, and B Ritchie, and N Mesaeli, and S Raha, and D Kolodziejczyk, and M L Hobman, and L Y Liu, and W Etches, and N Nation, and M Michalak, and A Lucas
June 2000, The Journal of clinical investigation,
E Dai, and M Stewart, and B Ritchie, and N Mesaeli, and S Raha, and D Kolodziejczyk, and M L Hobman, and L Y Liu, and W Etches, and N Nation, and M Michalak, and A Lucas
May 1995, Radiation research,
E Dai, and M Stewart, and B Ritchie, and N Mesaeli, and S Raha, and D Kolodziejczyk, and M L Hobman, and L Y Liu, and W Etches, and N Nation, and M Michalak, and A Lucas
April 2002, Arteriosclerosis, thrombosis, and vascular biology,
E Dai, and M Stewart, and B Ritchie, and N Mesaeli, and S Raha, and D Kolodziejczyk, and M L Hobman, and L Y Liu, and W Etches, and N Nation, and M Michalak, and A Lucas
August 2005, American journal of physiology. Regulatory, integrative and comparative physiology,
E Dai, and M Stewart, and B Ritchie, and N Mesaeli, and S Raha, and D Kolodziejczyk, and M L Hobman, and L Y Liu, and W Etches, and N Nation, and M Michalak, and A Lucas
February 2001, Journal of vascular surgery,
E Dai, and M Stewart, and B Ritchie, and N Mesaeli, and S Raha, and D Kolodziejczyk, and M L Hobman, and L Y Liu, and W Etches, and N Nation, and M Michalak, and A Lucas
September 2006, Arteriosclerosis, thrombosis, and vascular biology,
E Dai, and M Stewart, and B Ritchie, and N Mesaeli, and S Raha, and D Kolodziejczyk, and M L Hobman, and L Y Liu, and W Etches, and N Nation, and M Michalak, and A Lucas
July 2019, Vascular and endovascular surgery,
E Dai, and M Stewart, and B Ritchie, and N Mesaeli, and S Raha, and D Kolodziejczyk, and M L Hobman, and L Y Liu, and W Etches, and N Nation, and M Michalak, and A Lucas
February 2014, Journal of vascular surgery,
E Dai, and M Stewart, and B Ritchie, and N Mesaeli, and S Raha, and D Kolodziejczyk, and M L Hobman, and L Y Liu, and W Etches, and N Nation, and M Michalak, and A Lucas
January 2011, Journal of vascular research,
Copied contents to your clipboard!